Sort
38,696 grants matching “als”
SBIR phase II: A personalized, non-invasive hemoglobin level monitoring and management platform for chronic anemia patients.
$719,532Erika Amy Tyburski · Sanguina, Llc · R44 · FY2021 · HL
Expanding the reach of the Nutritious Eating with Soul (NEW Soul) program: A Type 2 hybrid effectiveness-implementation trial
$719,517Gabrielle Michelle Turner-McGrievy · University Of South Carolina At Columbia · R01 · FY2025 · HL
Genetics of ALS
$719,484Teepu Siddique · Northwestern University At Chicago · R01 · FY2007 · NS
Synthetic introns for selective targeting of RNA splicing factor-mutant leukemia
$719,414Robert K Bradley · Fred Hutchinson Cancer Center · R01 · FY2025 · CA
Fluorescence Microscopy
$719,272James W Putney · National Institute Of Environmental Health Sciences · ZIC · FY2012 · ES
Leveraging IVF to Identify Prenatal Effects Independent of Shared Maternal-Child Genes
$719,141Catherine E Monk · Columbia University Health Sciences · R01 · FY2025 · HD
The Frontal Lobes and Goal Selection Based on Strategies and Supramodal Inputs
$719,131Steven P Wise · National Institute Of Mental Health · Z01 · FY2007 · MH
Developing novel strategies for personalized treatment and prevention of ALS: Leveraging the global exposome, genome, epigenome, metabolome, and inflammasome with data science in a case/control cohort
$719,029Eva L Feldman · University Of Michigan At Ann Arbor · R01 · FY2024 · NS
The study of neuro-vascular interactions in the developing heart
$718,584Yoh-Suke Mukouyama · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
The study of neuro-vascular interactions in the central nervous system
$718,584Yoh-Suke Mukouyama · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Twin Family Study of Vulnerability to Substance Abuse
$718,505William G Iacono · University Of Minnesota · R37 · FY2016 · DA
Increasing access to opioid use disorder treatment by opening pharmacy-based medication units of opioid treatment programs
$718,340Li-Tzy T Wu · Duke University · R01 · FY2023 · DA
SCB Structural Cell Biology Core
$718,222John A Tainer · University Of Calif-Lawrenc Berkeley Lab · P01 · FY2012 · CA
Elucidating the Roles of Transposable Elements in Alzheimer's and related dementias
$718,190Peng Jin · Emory University · R01 · FY2025 · AG
Countermeasures Against Chemical Threats: Countermeasures Against Cyanide
$718,138Steven E Patterson · University Of Minnesota · U01 · FY2010 · NS
HIV-Receptor Interactions and Related Anti-HIV Strategies
$717,965Edward Berger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Stigma and the non-communicable disease syndemic in aging HIV positive and HIV negative MSM
$717,928Mackey R Friedman · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · HL
A Device to Enhance TENS Analgesic Effectiveness
$717,883Charles Chabal · Talaria, Inc. · R44 · FY2008 · CA
Molecular Pharmacology of NKT Cell Agonists
$717,836Luc Teyton · Scripps Research Institute, The · R01 · FY2014 · AI
Molecular Pharmacology of NKT Cell Agonists
$717,836Luc Teyton · Scripps Research Institute, The · R01 · FY2015 · AI
Pathophysiology and Treatment of Syringomyelia
$717,512John Heiss · National Institute Of Neurological Disorders And Stroke · ZIA · FY2019 · NS
Dissecting the Multivariate Genetic Architecture of Psychiatric Diseases
$717,398Elliot Max Tucker-Drob · University Of Texas At Austin · R01 · FY2020 · MH
CLINICAL DEVELOPMENT OF ISGYLATION DIAGNOSTIC BIOMARKER FOR ALS
$717,334Louisiana State University Health Sciences Center New Orleans · · FY2025 · Defense Health Agency
Therapeutic Targeting of RNA Splicing in Triple-Negative Breast Cancer
$717,288Thomas Westbrook · Baylor College Of Medicine · R01 · FY2023 · CA
Genomics and Proteomics of Head and Neck Cancer
$717,119Carter Van Waes · National Institute On Deafness And Other Communication Disorders · ZIA · FY2019 · DC